XTANT MED HLDGS INC's ticker is XTNT and the CUSIP is 98420P100. A total of 1 filers reported holding XTANT MED HLDGS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $33,000 | -23.3% | 58,150 | -1.9% | 0.00% | – |
Q3 2017 | $43,000 | +4.9% | 59,250 | -2.6% | 0.00% | – |
Q2 2017 | $41,000 | +41.4% | 60,850 | +32.9% | 0.00% | – |
Q1 2017 | $29,000 | +45.0% | 45,795 | +29.3% | 0.00% | – |
Q4 2016 | $20,000 | 0.0% | 35,413 | +93.5% | 0.00% | – |
Q3 2016 | $20,000 | – | 18,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PERKINS CAPITAL MANAGEMENT INC | 380,734 | $218,000 | 0.21% |
OUTFITTER ADVISORS, LTD. | 35,755 | $20,000 | 0.01% |
Winslow, Evans & Crocker, Inc. | 15,112 | $8,652,000 | 0.00% |
Orbimed Advisors | 4,754,386 | $272,000 | 0.00% |
Texas Yale Capital Corp. | 10,000 | $6,000 | 0.00% |
MORGAN STANLEY | 6,850 | $4,000 | 0.00% |
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 27,720 | $16,000 | 0.00% |
BlackRock Inc. | 1,455 | $1,000 | 0.00% |
Cambridge Investment Research Advisors, Inc. | 64,280 | $37,000 | 0.00% |
Citadel Advisors | 13,659 | $8,000 | 0.00% |